Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
01/2004
01/08/2004US20040006101 Quinolinone derivatives
01/07/2004EP1378230A1 Para-phenylenediamine derivatives comprising a pyrrolidinyl group substituted by a cyclic radical and their use in colouring keratinic fibres
01/07/2004EP1377558A1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists
01/07/2004CN1466588A Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
01/06/2004US6673921 Reduction and hydrogenolysis to form a benzodiazepine
01/06/2004US6673817 Anticoagulants
01/02/2004EP1373251A2 Non-imidazole compounds as histamine h3 antagonists
01/02/2004EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
12/2003
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/24/2003WO2003106628A2 Benzodiazepine inhibitors of mitochondial f>10< atp hydrolase and methods of inhibiting f>10< atp hydrolase
12/24/2003WO2003106444A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction
12/24/2003WO2003106428A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents
12/24/2003WO2003072558A3 Arylsulfone derivatives
12/24/2003CA2489450A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667303 Aryl substituted 1,4-diazepanes and method of use thereof
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/18/2003US20030232807 Dietetic agents
12/17/2003EP1202977B1 Process for manufacturing diazepine derivatives
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/17/2003CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/16/2003US6664353 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
12/16/2003US6664249 Bicyclic vasopressin agonists
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/10/2003EP1368009A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
12/10/2003CN1130351C 1,5-benzodiazepine derivatives
12/04/2003WO2003099797A1 Salts of bis-arylsulfones for the treatment of cns disorders
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225065 Use of 4-(1,4-diazepan-1-yl)- or 4-piperazin-1-yl-2-aminophenyl phenyl sulfones for treatment of disorders of the central nervous system.
11/2003
11/27/2003WO2003096989A2 Anti tubercular drug: compositions and methods
11/27/2003US20030220327 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazephine as HIV reverse transcriptase inhibitors
11/27/2003US20030220325 Such as 1-(4-(phenylsulfonyl)-naphthyl)piperazine; for treating treating diseases related to 5-HT receptor; radiolabelling
11/27/2003CA2485592A1 Anti tubercular drug: compositions and methods
11/26/2003EP1363605A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/18/2003US6649607 Compositions and methods for treating or preventing convulsions or seizures
11/18/2003US6649366 Methods and compositions related to modulators of annexin and cartilage homeostasis
11/13/2003WO2003015703A3 Compositions and methods relating to novel benzodiazepine compounds and targets thereof
11/12/2003CN1127488C Compouds with growth hormone releasing properties
11/11/2003US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003050092A3 Process for the preparation of tofisopam and new intermediates
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003US20030207866 Drugs useful for the treatment of diseases or disorders of the central nervous system.
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/04/2003US6642225 Diazacycloalkanedione derivatives
11/04/2003US6642224 Activated blood coagulation factor X inhibitors
11/04/2003US6642223 Benzoheterocyclic derivatives
10/2003
10/30/2003WO2003051275A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/30/2003WO2003051274A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/29/2003CN1452483A IL-8 receptor antagonists
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/23/2003US20030199499 Novel guanidinobenzamides
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/16/2003WO2003084610A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195193 Useful as activated blood coagulation factor X inhibitor; useful as an anticoagulant or an agent for prophylaxis and therapy of diseases caused by thrombus or embolus
10/16/2003CA2478227A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
10/15/2003EP1351942A1 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003CN1449382A Polyarylcarboxamides useful as lipid lowering agents
10/14/2003US6632812 Substituted lactams as inhibitors of Aβ protein production
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/09/2003WO2003082877A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003CA2480869A1 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003CA2479932A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/07/2003US6630472 Compounds, pharmaceutical compositions, and methods for stimulating neuronal growth and elongation
10/07/2003US6630462 Delta agonist analgesics
10/07/2003US6630461 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
10/02/2003US20030186969 Benzodiazepine derivatives
10/02/2003US20030186960 Nervous system regeneration
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/01/2003EP1347967A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
10/01/2003CN1446220A Method for the production of imidazo-[1,2-c] [2,3]-benzodiazepines and intermediates in production thereof
10/01/2003CN1122670C Thiazolobenzoheterocycles, prepn method and medicines containing same
09/2003
09/25/2003US20030181587 Thermoplastic resin composition
09/24/2003EP1346993A1 Lactam compounds and medicinal use thereof
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003US20030176420 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
09/17/2003EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
09/17/2003EP1030852B1 Oxazolidinone derivatives and pharmaceutical compositions
09/17/2003CN1121395C Compounds potentiating retinoid
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/12/2003WO2003074476A1 Novel arylamidine derivative or salt thereof
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 60